Second malignancy after treatment of acute promyelocytic leukemia: experience of GIMEMA trials. Gruppo Italiano Malattie Ematologiche dell'Adulto.
Livio
L
Pagano
Alessandro
A
Pulsoni
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D009190:Myelodysplastic Syndromes / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced*
D000970:Antineoplastic Agents